Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.
Looking at options history for Pfizer (NYSE:PFE) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $2,349,878 and 6, calls, for a total amount of $1,061,250.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $18.0 and $26.0 for Pfizer, spanning the last three months.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Pfizer's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $18.0 to $26.0 in the last 30 days.
Pfizer Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | PUT | TRADE | BEARISH | 09/12/25 | $0.94 | $0.9 | $0.93 | $26.00 | $2.3M | 169 | 24.8K |
| PFE | CALL | TRADE | BEARISH | 01/16/26 | $1.6 | $1.56 | $1.57 | $25.00 | $785.0K | 34.3K | 5.0K |
| PFE | CALL | TRADE | BEARISH | 06/18/26 | $7.5 | $7.45 | $7.45 | $18.00 | $74.5K | 461 | 200 |
| PFE | CALL | SWEEP | BULLISH | 06/18/26 | $7.4 | $7.3 | $7.4 | $18.00 | $74.0K | 461 | 0 |
| PFE | CALL | TRADE | BEARISH | 01/16/26 | $5.5 | $5.4 | $5.4 | $20.00 | $54.0K | 10.7K | 100 |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Following our analysis of the options activities associated with Pfizer, we pivot to a closer look at the company's own performance.
Present Market Standing of Pfizer
- With a trading volume of 11,574,408, the price of PFE is down by -0.36%, reaching $25.05.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 63 days from now.
Professional Analyst Ratings for Pfizer
3 market experts have recently issued ratings for this stock, with a consensus target price of $29.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from Citigroup continues to hold a Neutral rating for Pfizer, targeting a price of $26. * An analyst from Morgan Stanley persists with their Equal-Weight rating on Pfizer, maintaining a target price of $33. * Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for Pfizer, targeting a price of $28.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
